Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Everardus J. J. van Zoelen
Selective Formation of ErbB-2/ErbB-3 Heterodimers Depends on the ErbB-3 Affinity of Epidermal Growth Factor-Like Ligands
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Related publications
The Oncogenic ErbB-2/ErbB-3 Heterodimer Is a Surrogate Receptor of the Epidermal Growth Factor and Betacellulin
Oncogene
Cancer Research
Genetics
Molecular Biology
Single-Chain Antibody-Mediated Intracellular Retention of ErbB-2 Impairs Neu Differentiation Factor and Epidermal Growth Factor Signaling.
Molecular and Cellular Biology
Cell Biology
Molecular Biology
CLINICAL SIGNIFICANCE OF THE EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTOR AND C-erbB-2 PROTEIN IN THE BILE DUCT CANCER
The journal of the Japanese Practical Surgeon Society
ErbB-2 Blockade and Prenyltransferase Inhibition Alter Epidermal Growth Factor and Epidermal Growth Factor Receptor Trafficking and Enhance 111In-Dtpa-hEGF Auger Electron Radiation Therapy
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Betacellulin-Induced Beta Cell Proliferation and Regeneration Is Mediated by Activation of ErbB-1 and ErbB-2 Receptors
PLoS ONE
Multidisciplinary
Progesterone Receptor Induces ErbB-2 Nuclear Translocation to Promote Breast Cancer Growth via a Novel Transcriptional Effect: ErbB-2 Function as a Coactivator of Stat3
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Controlled Dimerization of ErbB Receptors Provides Evidence for Differential Signaling by Homo- And Heterodimers
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Epidermal Growth Factor Receptor, but Not C-erbB-2, Activation Prevents Lactogenic Hormone Induction of the Beta-Casein Gene in Mouse Mammary Epithelial Cells.
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Genetic Prodrug Activation in erbB-2 Overexpressing Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
